Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD

Clinical trial NCT06704321 · RECRUITING

Trial details

NCT number: NCT06704321
Sponsor: Valbiotis
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Non-Alcoholic Fatty Liver Disease

Start date: 2024-01-31
Primary completion: 2025-12-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.